| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.027 | 20.259 | 32.116 | 21.028 | 8.884 | 14.995 | 2.078 | 1.159 | 6.661 | 0 |
| Total Income - EUR | 40.032 | 20.283 | 32.080 | 21.046 | 9.142 | 14.995 | 14.893 | 1.159 | 6.662 | 0 |
| Total Expenses - EUR | 14.608 | 13.923 | 28.982 | 18.547 | 14.981 | 14.223 | 3.797 | 2.719 | 3.316 | 2.444 |
| Gross Profit/Loss - EUR | 25.424 | 6.360 | 3.098 | 2.499 | -5.840 | 772 | 11.096 | -1.560 | 3.346 | -2.444 |
| Net Profit/Loss - EUR | 24.223 | 5.954 | 2.777 | 2.289 | -5.931 | 622 | 10.658 | -1.595 | 2.822 | -2.444 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Siepromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 84.523 | 83.028 | 81.403 | 79.570 | 77.630 | 75.864 | 72.862 | 73.287 | 72.960 | 72.553 |
| Current Assets | 67.860 | 61.171 | 63.835 | 62.672 | 56.006 | 29.971 | 40.515 | 38.428 | 27.689 | 24.995 |
| Inventories | 1.545 | 2.753 | 2.519 | 2.633 | 2.738 | 2.686 | 2.644 | 2.732 | 2.745 | 2.729 |
| Receivables | 26.522 | 24.145 | 21.260 | 18.944 | 21.199 | 22.148 | 15.350 | 15.620 | 13.818 | 14.029 |
| Cash | 39.793 | 34.273 | 40.056 | 41.095 | 32.069 | 5.137 | 22.521 | 20.077 | 11.127 | 8.238 |
| Shareholders Funds | 132.628 | 103.744 | 103.712 | 104.006 | 96.046 | 94.778 | 103.334 | 89.650 | 92.200 | 89.241 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 0 |
| Debts | 19.755 | 40.454 | 41.525 | 38.236 | 37.589 | 11.057 | 10.043 | 22.065 | 8.450 | 8.307 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Siepromed S.r.l.